De-escalation of oral P2Y12 inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitus

被引:0
|
作者
Capranzano, Piera [1 ]
Angiolillo, Dominick J. [2 ]
机构
[1] Univ Catania, Div Cardiol, CAST Policlin Hosp, Via S Sofia 78, I-95123 Catania, Italy
[2] Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL USA
关键词
ACUTE CORONARY SYNDROME; TROPICAL-ACS; ANTIPLATELET TREATMENT; FUNCTION PROFILES; ARTERY-DISEASE; CLOPIDOGREL; OUTCOMES; THERAPY; INTERVENTION; GUIDELINES;
D O I
10.4244/EIJV15I6A89
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:E486 / E489
页数:4
相关论文
共 50 条
  • [21] Drug Interaction: Opioids and Oral P2Y12 Platelet Inhibitors
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1566): : 31 - 32
  • [22] Impact of cangrelor on P2Y12 mediated platelet reactivity in patients with diabetes mellitus and coronary artery disease
    Gutierrez, J. L. Ferreiro
    Ueno, M.
    Alissa, R.
    Dharmashankar, K.
    Capodanno, D.
    Desai, B.
    Bass, T. A.
    Angiolillo, D. J.
    CARDIOVASCULAR RESEARCH, 2010, 87 : S96 - S96
  • [23] Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
    Eliaz, R.
    Mengesha, B.
    Ovdat, T.
    Iakobishvili, Z.
    Hasdai, D.
    Kheifets, M.
    Klempfner, R.
    Beigel, R.
    Kalmanovich, E.
    Alcalai, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1414 - 1414
  • [24] Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors
    Levens, Amar D.
    den Haan, Melina C.
    Jukema, J. Wouter
    Heringa, Mette
    van den Hout, Wilbert B.
    Moes, Dirk Jan A. R.
    Swen, Jesse J.
    GENES, 2023, 14 (03)
  • [25] Impact of chronic kidney disease on platelet P2Y12 receptor signalling in patients with type 2 diabetes mellitus
    Engwenyu, Lydia R.
    Franchi, Francesco
    Rollini, Fabiana
    Cho, Jung Rae
    DeGroat, Christopher
    Bhatti, Mona
    Alobaidi, Zeina
    Ferrante, Elisabetta
    Jakubowski, Joseph A.
    Sugidachi, Atsuhiro
    Zenni, Martin M.
    Bass, Theodore A.
    Angiolillo, Dominick J.
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (01) : 201 - 203
  • [26] Mode of action of P2Y12 antagonists as inhibitors of platelet function
    Glenn, J.
    Iyu, D. E.
    White, A. E.
    Fox, S. C.
    van Giezen, H.
    Nylander, S.
    Heptinstall, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 319 - 320
  • [27] Mode of action of P2Y12 antagonists as inhibitors of platelet function
    Iyu, David
    Glenn, Jackie R.
    White, Ann E.
    Fox, Sue C.
    van Giezen, Hans
    Nylander, Sven
    Heptinstall, Stan
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (01) : 96 - 106
  • [28] Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients
    Azzahhafi, Jaouad
    van den Broek, Wout W. A.
    Yin, Dean R. P. P. Chan Pin
    van der Sangen, Niels M. R.
    Sivanesan, Shabiga
    Bofarid, Salahodin
    Peper, Joyce
    Claassens, Daniel M. F.
    Janssen, Paul W. A.
    Harmsze, Ankie M.
    Walhout, Ronald J.
    Gin, Melvyn Tjon Joe
    Nicastia, Deborah M.
    Langerveld, Jorina
    Vlachojannis, Georgios J.
    van Bommel, Rutger J.
    Appelman, Yolande
    van Schaik, Ron H. N.
    Henriques, Jose P. S.
    Kikkert, Wouter J.
    ten Berg, Jurrien M.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (17) : 1996 - 2007
  • [29] ONE-YEAR COST-EFFECTIVENESS OF CYP2C19-GUIDED DE-ESCALATION AND ESCALATION OF P2Y12 INHIBITORS IN VETERANS WITH ACUTE CORONARY SYNDROMES UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Dong, Olivia
    Friede, Kevin
    Chanfreau-Coffinier, Catherine
    Voora, Deepak
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3416 - 3416
  • [30] Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation
    Verheugt, Freek W. A.
    Huber, Kurt
    Clemmensen, Peter
    Collet, Jean-Philippe
    Cuisset, Thomas
    Andreotti, Felicita
    THROMBOSIS AND HAEMOSTASIS, 2023, 123 (02) : 159 - 165